|When did Hospira begin trading as a publicly traded company?|
|Hospira was spun off from Abbott on April 30, 2004 and began trading as a publicly traded company on the New York Stock Exchange under the ticker “HSP” on May 3, 2004.
|What is Hospira’s stock ticker?|
|Hospira common stock is listed as HSP on the New York Stock Exchange.
|Where is Hospira’s stock traded?|
|Hospira common stock is listed as HSP on the New York Stock Exchange, which is the principal market where the company’s stock is traded.
|What is Hospira’s CUSIP number?|
|Hospira’s CUSIP number is 441060100.
|What is Hospira’s fiscal year?|
|Hospira’s fiscal year ends on December 31.
|Where are Hospira’s corporate headquarters?|
|Hospira is headquartered in Lake Forest, Ill., just north of Chicago.
|Who are the members of Hospira’s board of directors?|
|Click here to view a listing of and information about the members of Hospira’s board of directors.
|How can I contact Hospira? How can I contact Investor Relations?|
|You can contact Hospira through email by clicking here for general or investor-related questions. In addition, you can reach Investor Relations at 224.212.2711 or by fax at 224.212.3437.
|What is Hospira's profile?|
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Headquartered north of Chicago in Lake Forest, Ill., Hospira has approximately 16,000 employees worldwide and generated approximately $4.1 billion in net sales in 2012.To learn more, click here.
|How can I get copies of Hospira’s annual reports or press releases?|
|Hospira's annual reports and press releases are available online. If you wish to receive a printed version of the annual report, you may contact the company to request investor material online.
|How can I get more information about Hospira?|
| Additional information is also available on the Web site in the “About Hospira” section, which you can access by clicking here. Hospira's annual reports and press releases are also available online. You may contact the company directly if you wish to receive a printed version of the annual report, or request investor material online.
|Is there a way to be alerted when new investor information is posted to the Investor Relations section of Hospira’s website?|
|You may automatically receive e-mail alerts about Hospira SEC filings, upcoming events, presentations and archived webcasts, and end-of-day stock alerts by clicking here. If you wish to be alerted when a new Hospira press release is posted, please click here.
|When does Hospira hold its annual meeting?|
|Hospira generally holds its annual meetings in May. Notice of the meetings is issued in the proxy statement, available at the Proxy Materials page.
|Can I elect to receive my proxy materials electronically as opposed to by mail? How do I do that?|
|Hospira shareholders may elect to receive proxy statements and annual reports online. In addition to reducing the amount of paper mailed to shareholders, this saves the company printing and mailing costs. To enroll for Hospira’s E-Delivery service, which is free of cost, click here.
|How can I buy or sell Hospira stock?|
|Hospira common stock is listed as HSP on the New York Stock Exchange. Shares can be bought or sold through any financial institution that provides brokerage services.
|Can I purchase stock directly from Hospira? Does Hospira have a direct stock purchase plan?|
|Hospira does not have a direct purchase plan. Please contact a stockbroker to purchase Hospira shares.
|Does Hospira issue dividends or have a DRIP (Dividend Reinvestment Program)?|
|Hospira does not pay a dividend at this time; therefore, it does not have dividend reinvestment plan.
|Why didn’t I receive a stock certificate for the shares of Hospira stock I received at the time of the spin-off from Abbott?|
Hospira uses the Direct Registration system for its shares, a paperless form of stock ownership commonly referred to as “book entry,” that allows your shares to be held in your name and tracked electronically. You retain full ownership of your shares without having to hold a paper stock certificate. Because Hospira uses the book-entry system, at the time of spin-off, Abbott shareholders receiving Hospira stock did not receive actual stock certificates.
Shares held in book-entry have all the traditional rights and privileges as shares held in certificate form. Furthermore, by keeping your shares in book-entry, you do not have to worry about protecting your stock certificates from loss, theft or destruction. Book-entry ownership also allows for electronic share transactions, such as ownership transfers, sales and moving shares to or from a broker.
|I’m a registered shareholder. Can I access my account online?|
|Yes. Registered Hospira shareholders can access their accounts online by visiting www.computershare.com, where instructions are provided on how to access individual accounts.
|Who are Hospira’s independent auditors?|
|Deloitte & Touche LLP are Hospira’s independent auditors.
|Questions Related to the spin-off from Abbott|
|How can I determine the tax basis I have in the Hospira shares received in the distribution of Hospira stock at spin-off?|
|Click here for information for U.S. shareholders regarding how to compute their tax basis in both Abbott and Hospira shares, as well as additional tax information, including guidance on how to split the cost between Abbott and Hospira shares. You should consult your tax advisor about your particular situation, including the application of state, local and foreign tax laws.|
|Did Abbott shareholders have to pay U.S. federal income taxes on receipt of Hospira shares at spin-off?|
|Abbott received a ruling from the Internal Revenue Services that, for U.S. federal income tax purposes, the distribution of Hospira common stock was tax-free to Abbott and to Abbott's U.S. shareholders to the extent that they received Hopsira common stock. However, fractional shares were not issued, and any cash received in lieu of fractional shares generally was taxable. Additional information, including guidance on how to split the cost basis between Abbott and Hospira shares, is available by clicking here. You should consult your tax advisor about your particular situation, including the application of state, local and foreign tax laws.
Click here for more information